A Phase 3 interventional study of Albumin (5% serum-protein solution containing immunoglobulins) and connective tissue graft in Deficient Interdental Papilla, sponsored by ahmed mostafa ahmed abo el soud. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.
Sponsored by ahmed mostafa ahmed abo el soud · Phase 3, Interventional, and Treatment
This study will evaluate the efficacy of Alb PRF membrane in comparison to a subepithelial connective tissue graft in the reconstruction of interdental papillae.
the reconstruction will be done using the Hans Taki surgical technique, while Alb PRF will be used as a membrane.
This is the only study on the registry with ahmed mostafa ahmed abo el soud as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Biological: connective tissue graft
Biological: Albumin (5% serum-protein solution containing immunoglobulins)
a variation of PRF done by heating up to 75 degree then mixed with the remaining prf to get membrane
subepithelial connective tissue graft
papillary height measured from apical part of contact point to tip of papilla (CP-TP)
Time frame: from enrollment, 3 months, 6months, 9months, 12months
No study locations are listed for this record.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.